Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1116 Mechanisms of tumor-intrinsic immune cloaking in neoantigen-rich cancers

  • Arup Chakraborty1
  • Salah Boudjadi2
  • Sandeep Gurram3
  • Weiming Yang4
  • Abbas Yousefi-Rad5
  • Dhanusha Yesudhas
  • Bilal Lone
  • Ecem Unal1
  • Ayse G Keskus1
  • Jaimie Ryou1
  • Kelly Butler1
  • Tania Colon Aquino1
7 more authors
  • Lisa Jenkins1
  • Elias Chandran1
  • Raju Chelluri1
  • Vladimir Valera Romero1
  • Mikhail Kolmogorov1
  • Andrea B Apolo1
  • A Rouf Banday1
5 affiliations
  1. 1National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
  2. 2Genitourinary Malignancies Branch, National Institutes of Health, Bethesda, Maryland, USA
  3. 3Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
  4. 41 Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, Liaoning, China
  5. 51National Cancer Institute, National Institutes of Health, Rockville, MD, USA
Open at sourcePDFDOICite

Related

  1. Characterization of circulating neoantigen-specific T cell responses and public T cell receptors shaping immune memory in Lynch syndrome carriers
    Fahriye Duzagac, Nan Deng, Jinling Wang +5
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  2. Predicting Neoantigen Immunogenicity from In Vivo Immune Editing
    T. J. Sears, K.-h. Lee, M. Munoz Perez +7
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  3. Interpreting the Early Cancer Peak in Immune-Mediated Inflammatory Diseases. Comment on Giordani et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers 2026, 18, 1027
    Alper Gumustepe, Esra Gumustepe
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  4. Reply to Gumustepe, A.; Gumustepe, E. Comment on “Giordani et al. Cancer Association in Patients with Immune-Mediated Inflammatory Diseases: A Five-Year Nationwide Italian Cohort Study. Cancers 2026, 18, 3449”
    Barbara Giordani, Luigi Pirtoli, Guido Putignano +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Functional Deorphanization of Tumor-reactive TCRs Uncovers a Landscape of Shared, Immune Dominant Antigens across Cancers
    O. Bricard, R. Seyed Rahmani, F. Peeters +14
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv

Cite

BibTeXRIS
BibTeX
@article{chakraborty20261116,
  title = {{1116 Mechanisms of tumor-intrinsic immune cloaking in neoantigen-rich cancers}},
  author = {Arup Chakraborty and Salah Boudjadi and Sandeep Gurram and Weiming Yang and Abbas Yousefi-Rad and Dhanusha Yesudhas and Bilal Lone and Ecem Unal and Ayse G Keskus and Jaimie Ryou and Kelly Butler and Tania Colon Aquino and Lisa Jenkins and Elias Chandran and Raju Chelluri and Vladimir Valera Romero and Mikhail Kolmogorov and Andrea B Apolo and A Rouf Banday},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1116},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1116},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1116 Mechanisms of tumor-intrinsic immune cloaking in neoantigen-rich cancers
AU  - Arup Chakraborty
AU  - Salah Boudjadi
AU  - Sandeep Gurram
AU  - Weiming Yang
AU  - Abbas Yousefi-Rad
AU  - Dhanusha Yesudhas
AU  - Bilal Lone
AU  - Ecem Unal
AU  - Ayse G Keskus
AU  - Jaimie Ryou
AU  - Kelly Butler
AU  - Tania Colon Aquino
AU  - Lisa Jenkins
AU  - Elias Chandran
AU  - Raju Chelluri
AU  - Vladimir Valera Romero
AU  - Mikhail Kolmogorov
AU  - Andrea B Apolo
AU  - A Rouf Banday
PY  - 2026
DA  - 2026/11/09
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1116
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1116
SN  - 2051-1426
ER  -